Abaxis, Inc. (ABAX) Clibs to All Time High at $83.34 on May, 17

May 16, 2018 - By Robert Shackelford

Abaxis, Inc. (NASDAQ:ABAX) Corporate Logo

Big Money Sentiment decreased to 1.27 in 2017 Q4. It has change of 0.05, from 2017Q3’s 1.32. The ratio dived due to Abaxis, Inc. positioning: 12 sold and 40 reduced. 25 funds bought stakes and 41 increased stakes. Investors holded 21.83 million in 2017Q3 but now own 21.66 million shares or 0.81% less.
Tiaa Cref Investment Limited Liability Com has invested 0% in Abaxis, Inc. (NASDAQ:ABAX). Bridgeway Cap Mgmt Inc holds 0.01% of its capital in Abaxis, Inc. (NASDAQ:ABAX) for 15,300 shs. Schwab Charles Investment Management, California-based fund reported 111,019 shs. The Connecticut-based Point72 Asset Management Ltd Partnership has invested 0% in Abaxis, Inc. (NASDAQ:ABAX). Moreover, Hl Fincl Svcs Ltd Llc has 0% invested in Abaxis, Inc. (NASDAQ:ABAX) for 4,653 shs. Sector Pension Investment Board reported 14,254 shs. 24,194 were accumulated by Credit Suisse Ag. Ameritas Invest Prns Inc owns 1,894 shs for 0% of their capital. Kayne Anderson Rudnick Invest Ltd Co reported 3.66 million shs stake. Financial Bank Of Montreal Can stated it has 0% in Abaxis, Inc. (NASDAQ:ABAX). Assetmark Incorporated accumulated 8 shs. Riverhead Capital Management Ltd Liability Corp owns 2,253 shs for 0% of their capital. Teachers Retirement Systems Of The State Of Kentucky reported 8,600 shs stake. Northern Tru has 0% invested in Abaxis, Inc. (NASDAQ:ABAX) for 286,577 shs. Parkside Bancorp & has invested 0% in Abaxis, Inc. (NASDAQ:ABAX).

Abaxis, Inc. registered $2.85 million net activity with 0 insider buys and 10 sales since January 30, 2018. SINGH PRITHIPAL had sold 2,000 shs worth $140,500 on Tuesday, March 6. $304,953 worth of Abaxis, Inc. (NASDAQ:ABAX) shs were sold by Henkel Achim. Shares for $355,327 were sold by CASEY MICHAEL D. EVENHUIS HENK also sold $333,460 worth of Abaxis, Inc. (NASDAQ:ABAX) shs. The insider TOCKMAN CRAIG sold $122,652. Another trade for 10,000 shs valued at $689,851 was made by WOOD DONALD PETER on Tuesday, March 6.

Abaxis, Inc. (NASDAQ:ABAX) touched all time high on May, 17 with $88.34 target or 6.00 % above the last $83.34 share price. The all time high was reported by Barchart.com. The company has $1.89 billion MC. At our $88.34 target, the company worth will be $113.52 million more.

The stock increased 16.15% or $11.59 during the last trading session, reaching $83.34.Abaxis, Inc. has 4.19M shares volume, 2804.89% up from normal. ABAX is uptrending and has moved 44.47% since May 17, 2017. ABAX outperformed by 32.92% the S&P 500.

Abaxis, Inc. (NASDAQ:ABAX)’s quarterly earnings will be revealed on July, 26., Zacks reports. Last year’s EPS was $0.28, while now analysts expect change of 25.00 % up from current $0.35 EPS. ABAX’s profit could hit $7.95 million if the current EPS of $0.35 is accurate. After $0.42 EPS was revealed previous quarter, analysts now see negative EPS growth of -16.67 % for Abaxis, Inc..

Abaxis, Inc. (NASDAQ:ABAX) Ratings Coverage

In total 7 analysts cover Abaxis (NASDAQ:ABAX). “Buy” rating has 1, “Sell” are 1, while 5 are “Hold”. 14% are bullish. With $90.0 highest and $48 lowest target Abaxis has $65 average target or -22.01% below the current ($83.34) price. 11 are the (NASDAQ:ABAX)’s analyst reports since November 30, 2017 according to StockzIntelligence Inc. On Tuesday, January 16 the firm has “Hold” rating given by Canaccord Genuity. In Monday, January 29 report Northcoast maintained it with “Buy” rating and $90.0 target. On Monday, January 29 the firm earned “Hold” rating by Canaccord Genuity. The stock rating was upgraded by Raymond James to “Hold” on Tuesday, January 9. On Wednesday, May 16 the stock of Abaxis, Inc. (NASDAQ:ABAX) has “Neutral” rating given by Sidoti. On Tuesday, January 9 Northcoast maintained Abaxis, Inc. (NASDAQ:ABAX) with “Buy” rating. On Friday, April 27 the stock of Abaxis, Inc. (NASDAQ:ABAX) has “Hold” rating given by Stifel Nicolaus. On Friday, January 26 the rating was maintained by Stephens with “Hold”. On Thursday, February 8 Bank of America maintained Abaxis, Inc. (NASDAQ:ABAX) rating. Bank of America has “Underperform” rating and $48 target. In Thursday, January 25 report Stifel Nicolaus maintained it with “Hold” rating and $57.0 target.

For more Abaxis, Inc. (NASDAQ:ABAX) news posted recently go to: Benzinga.com, Benzinga.com, Prnewswire.com, Themiddlemarket.com or Fool.com. The titles are as follows: “A Preview Of Abaxis Q4 Earnings” posted on April 26, 2018, “40 Stocks Moving In Wednesday’s Mid-Day Session” on May 16, 2018, “ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Abaxis, Inc.” with a publish date: May 16, 2018, “M&A daily wrap: NFL’s Carolina Panthers, Cam Newton, David Tepper, Appaloosa, Brynwood Partners” and the last “Why Under Armour, Boot Barn Holdings, and Abaxis Jumped Today” with publication date: May 16, 2018.

Abaxis, Inc. develops, manufactures, markets, and sells portable blood analysis systems for use in human or veterinary patient care settings to provide rapid blood constituent measurements for clinicians worldwide.The firm is worth $1.89 billion. It operates in two divisions, Medical Market and Veterinary Market.77.17 is the P/E ratio. The firm offers Piccolo chemistry analyzers with rapid blood constituent measurements for use in human patient care; and Piccolo profiles that are single-use medical reagents.

Abaxis, Inc. (NASDAQ:ABAX) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.